In a Senate hearing Wednesday, Georgia Congressman and former physician Tom Price, who is President-elect Donald Trump’s pick to head the powerful Department of Health and Human Services, was grilled about stock purchases in health care, pharmaceutical, and medical device companies that may have posed a conflict of interest.
Such questions are right on target.
Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!
GET STARTEDWhat is it?
STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.
What's included?
- Daily reporting and analysis
- The most comprehensive industry coverage from a powerhouse team of reporters
- Subscriber-only newsletters
- Daily newsletters to brief you on the most important industry news of the day
- Online intelligence briefings
- Frequent opportunities to engage with veteran beat reporters and industry experts
- Exclusive industry events
- Premium access to subscriber-only networking events around the country
- The best reporters in the industry
- The most trusted and well-connected newsroom in the health care industry
- And much more
- Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
congress caused the problem in the first place
re; the medicare part b -bundled reimbusements for orthopedics issue:
many hit with big hospital bills because of cheap Conway- cms medicare arbitrary decisions
and they had to wait months for this issue to be resolved
medicare should deal with real issues like ban hospitals using outside consultants without patient permi$$ion. that who rock socks you with the bills1
Yours is just evil liberal propaganda.
He is white, he is an MD, he is rich, he goes to church, ergo he must be a good and capable person
Thank you for the correction. The AMA did not lobby against ACA; once the ACA came into being after concessions from many interests, the AMA was supportive
https://www.publicintegrity.org/2010/02/24/2725/lobbyists-swarm-capitol-influence-health-reform. They were against President Obama’s early efforts towards enhancing public options for health care reform https://mobile.nytimes.com/2009/06/11/us/politics/11health.html
Although I’d seen several articles on AMA membership decline http://www.medscape.com/viewarticle/830152_7, a more recent search found some indicating increases in recent years after “the decades-long membership decline.” http://associationsnow.com/2015/02/medical-association-heres-whats-behind-our-member-surge/ At least some of the increase is noted to come from reduced fees offered to students and residents.
Linked this article into my current blog post (KHIT.org, January 19th). Looks to me at this point — unhappily — that Price will be confirmed.